Toby A. Dite

Toby A. Dite

Auto-generated profile, based on publicly available information

Toby A. Dite

Department of Medicine, The University of Melbourne, St. Vincent's Hospital, Melbourne, VIC, 3065, Australia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 July 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
CVChristina Vrahnas
Christina Vrahnas
MBMartha Blank
Martha Blank
TDToby A. Dite
Toby A. Dite
LTLiliana Tatarczuch
Liliana Tatarczuch
NANiloufar Ansari
Niloufar Ansari
NSNatalie A. Sims
Natalie A. Sims
Mineralized bone forms when collagen-containing osteoid accrues mineral crystals. This is initiated rapidly (primary mineralization), and continues slowly (secondary mineralization) until bone is remodeled. The interconnected osteocyte network within the bone matrix differentiates from bone-forming osteoblasts; although osteoblast differentiation requires EphrinB2, osteocytes retain its expression. Here we report brittle bones in mice with osteocyte-targeted EphrinB2 deletion. This is not caused by low bone mass, but by defective bone material. While osteoid mineralization is initiated at normal rate, mineral accrual is accelerated, indicating that EphrinB2 in osteocytes limits mineral accumulation. No known regulators of mineralization are modified in the brittle cortical bone but a cluster of autophagy-associated genes are dysregulated. EphrinB2-deficient osteocytes displayed more autophagosomes in vivo and in vitro, and EphrinB2-Fc treatment suppresses autophagy in a RhoA-ROCK dependent manner. We conclude that secondary mineralization involves EphrinB2-RhoA-limited autophagy in osteocytes, and disruption leads to a bone fragility independent of bone mass.

4 November 2019 in Nature Communications
Verified
Journal Article
Open access
CVChristina Vrahnas
Christina Vrahnas
MBMartha Blank
Martha Blank
TDToby A. Dite
Toby A. Dite
LTLiliana Tatarczuch
Liliana Tatarczuch
NANiloufar Ansari
Niloufar Ansari
NSNatalie A. Sims
Natalie A. Sims
An amendment to this paper has been published and can be accessed via a link at the top of the paper.

19 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
KBKatrina A Black
Katrina A Black
JMJesse I Mobbs
Jesse I Mobbs
HVHariprasad Venugopal
Hariprasad Venugopal
TDToby A Dite
Toby A Dite
ALAndrew Leis
Andrew Leis
AGAlisa Glukhova
Alisa Glukhova
Wnt signalling is essential for embryonic development and tissue homeostasis, and its dysregulation is associated with multiple types of cancer. Porcupine (PORCN), an endoplasmic reticulum (ER)-resident membrane-bound O-acyltransferase, catalyses the palmitoylation of all 19 human Wnts—a critical modification required for their secretion and activity. This central role makes PORCN an attractive therapeutic target for Wnt-driven cancers, with several inhibitors currently in clinical trials. Here, we present high-resolution cryo-electron microscopy structures of human PORCN in complex with the inhibitors C59 (2.4 Å) and ETC159 (2.6 Å), as well as in a ligand-free state (3.3 Å). These structures reveal critical ordered water molecules that form a hydrogen-bonding network within the active site, mediating inhibitor binding. Our docking simulations of diverse PORCN inhibitors demonstrate that despite their different chemical scaffolds, these compounds adopt similar conformations within the acyl-CoA binding site and are also engaged through a conserved water molecule. Our findings provide a structural foundation for the rational design of next-generation PORCN inhibitors with improved pharmacological properties for cancer therapy.